Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Novartis discloses protein atonal homolog 1 activators

Oct. 18, 2018

Insm1 keeps hair cells in 'n' out

Oct. 17, 2018

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Aug. 20, 2018

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Otonomy initiates additional phase III trial of Otividex for Meniere's disease

July 27, 2018

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

July 25, 2018

Addition of sodium thiosulfate to cisplatin lowers incidence of cisplatin-induced hearing loss

July 24, 2018

Hearing light, no synesthesia required

July 18, 2018

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...